Back to mobile site

Sangamo Biosciences (SGMO) Tops Q4 EPS by 1c

February 9, 2016 4:05 PM EST

Sangamo Biosciences (NASDAQ: SGMO) reported Q4 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $9.86 million.

For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings